Patents by Inventor Per Torp Sangild

Per Torp Sangild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN
    Publication number: 20220008444
    Abstract: The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
    Type: Application
    Filed: April 29, 2021
    Publication date: January 13, 2022
    Inventor: Per Torp Sangild
  • Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
    Patent number: 11135232
    Abstract: The invention discloses a composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising from 40 to 80 wt % of fucosylated oligosaccharide(s), from 10 to 50 wt % of N-acetylated oligosaccharide(s), from 5 to 40 wt % of sialylated oligosaccharide(s) and from 0 to 20 wt % of precursor(s) of human milk oligosaccharide, for use in preventing and/or in treating necrotizing enterocolitis in infants and young children.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: October 5, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventor: Per Torp Sangild
  • COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS OR YOUNG CHILDREN BORN BY C-SECTION
    Publication number: 20210228602
    Abstract: The present invention relates to a composition comprising at least one human milk oligosaccharide and/or a precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants or young children born by C-section.
    Type: Application
    Filed: February 3, 2021
    Publication date: July 29, 2021
    Inventor: Per Torp Sangild
  • Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
    Patent number: 11020413
    Abstract: The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: June 1, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventor: Per Torp Sangild
  • Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
    Patent number: 10940158
    Abstract: The present invention relates to a composition comprising at least one human milk oligosaccharide and/or a precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants or young children born by C-section.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: March 9, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventor: Per Torp Sangild
  • Bovine colostrum as minimal enteral nutrition for preterm infants
    Patent number: 9572365
    Abstract: The invention relates to a product consisting of bovine colostrum for use in a method for minimal enteral nutrition for preterm infants, which product is given according to a specified dosage regime, while supplemental nutrients are supplied by total parenteral nutrition during at least the chief part of the treatment period. In a second aspect is provided the use of said product as minimal enteral nutrition for preterm infants according to the first aspect of the invention.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: February 21, 2017
    Assignee: KØBENHAVNS UNIVERSITET
    Inventor: Per Torp Sangild
  • COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN
    Publication number: 20160296540
    Abstract: The invention discloses a composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising from 40 to 80 wt % of fucosylated oligosaccharide(s), from 10 to 50 wt % of N-acetylated oligosaccharide(s), from 5 to 40 wt % of sialylated oligosaccharide(s) and from 0 to 20 wt % of precursor(s) of human milk oligosaccharide, for use in preventing and/or in treating necrotizing enterocolitis in infants and young children.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 13, 2016
    Applicant: NESTEC S.A.
    Inventor: Per Torp Sangild
  • COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS OR YOUNG CHILDREN BORN BY C-SECTION
    Publication number: 20160296542
    Abstract: The present invention relates to a composition comprising at least one human milk oligosaccharide and/or a precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants or young children born by C-section.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 13, 2016
    Applicant: NESTEC S.A.
    Inventor: Per Torp Sangild
  • COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN
    Publication number: 20160296541
    Abstract: The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 13, 2016
    Applicant: NESTEC S.A.
    Inventor: Per Torp Sangild
  • BOVINE COLOSTRUM AS MINIMAL ENTERAL NUTRITION FOR PRETERM INFANTS
    Publication number: 20150216212
    Abstract: The invention relates to a product consisting of bovine colostrum for use in a method for minimal enteral nutrition for preterm infants, which product is given according to a specified dosage regime, while supplemental nutrients are supplied by total parenteral nutrition during at least the chief part of the treatment period. In a second aspect is provided the use of said product as minimal enteral nutrition for preterm infants according to the first aspect of the invention.
    Type: Application
    Filed: June 7, 2013
    Publication date: August 6, 2015
    Applicant: KØBENHAVNS UNIVERSITET
    Inventor: Per Torp Sangild